Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mastocytosis, Systemic × AK002 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mastocytosis, Systemic 1 Mastocytosis 1

Interventions

avapritinib 4 midostaurin 3 masitinib 2 Imatinib Mesylate 2 sarilumab 1 ripretinib 1 obatoclax 1 nilotinib 1 ibrutinib 1 denileukin diftitox 1 Thalidomide 1 Phlebotomy 1 Interviews as Topic 1 Everolimus 1 Denosumab 1 Dasatinib 1 Cladribine 1 Brentuximab Vedotin 1 AK002 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02808793 2019-03-13

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002

Allakos Inc.

Phase 1 Completed

Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡